Reply: Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy

Lisa Iversen, Philip C. Hannaford, Shona Fielding

Research output: Contribution to journalComment/debate

Abstract

We thank Dr Grant for her continued interest in our study. The Royal College of General Practitioners’ (RCGP) Oral Contraception Study has prospectively followed up women forward in time, with information about oral contraceptive (OC) exposure collected often many years before the diagnosis of cancer.
Original languageEnglish
Pages (from-to)233
Number of pages1
JournalAmerican Journal of Obstetrics and Gynecology
Volume217
Issue number2
Early online date11 May 2017
DOIs
Publication statusPublished - Aug 2017

Fingerprint Dive into the research topics of 'Reply: Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy'. Together they form a unique fingerprint.

  • Cite this